Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access
Open Access
- 15 March 2016
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 16 (1) , 1-8
Abstract
Essential medicines (EMs) are those medicines which satisfy the priority health care needs of the population. Although it is a fundamental human right, access to essential medicines has been a big challenge in developing countries particularly for children. WHO recommends assessing the current situations on availability and affordability of EMs as the first step towards enhancing access to them. Therefore, the aim of this study was to assess access to EMs for children based on availability, affordability, and price. We adapted the WHO and Health Action International tools to measure availability, affordability, and prices of EMs. We collected data on 22 EMs for children from 15 public to 40 private sectors’ drug outlets in east Wollega zone. Availability was expressed as percentage of drug outlets per sector that stocked surveyed medicines on the day of data collection, and prices were expressed as median price ratio. Affordability was measured as the number of daily wages required for the lowest-paid government unskilled worker (1.04 US $per day) to purchase one standard treatment of an acute condition or treatment for a chronic condition for a month. The average availability of essential medicines was 43 % at public and 42.8 % at private sectors. Lowest priced medicines were sold at median of 1.18 and 1.54 times their international reference prices (IRP) in the public and private sectors, respectively. Half of these medicines were priced at 0.90 to 1.3 in the public sector and 1.23 to 2.07 in the private sector times their respective IRP. Patient prices were 36 % times higher in the private sector than in the public sector. Medicines were unaffordable for treatment of common conditions prevalent in the zone at both public and private sectors as they cost a day or more days’ wages for the lowest paid government unskilled worker. Access to EMs to children is hampered by low availability and high price which is unaffordable. Thus, further study on larger scale is critical to identify acute areas for policy interventions such as price and or supply, and to enhance access to EMs to children.Keywords
Funding Information
- Wollega University, Ethiopia
This publication has 22 references indexed in Scilit:
- Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of ChinaPLOS ONE, 2013
- Access to Essential Medicines in Pakistan: Policy and Health Systems Research ConcernsPLOS ONE, 2013
- Access to medicines in Latin America and the Caribbean (LAC): a scoping studyBMJ Open, 2013
- Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines ListsPLOS ONE, 2012
- Availability, prices and affordability of the World Health Organization’s essential medicines for children in GuatemalaGlobalization and Health, 2012
- Prices, availability and affordability of essential medicines in rural areas of Hubei Province, ChinaHealth Policy and Planning, 2009
- What essential medicines for children are on the shelf?Bulletin of the World Health Organization, 2009
- Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysisThe Lancet, 2009
- Medicines Prices and Malaysia—Untangling the Medicines WebPLOS Medicine, 2007
- Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in MalaysiaPLOS Medicine, 2007